Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 2 | 2022 | 407 | 1.320 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 768 | 1.240 |
Why?
|
| Staining and Labeling | 3 | 2022 | 1100 | 1.220 |
Why?
|
| Azo Compounds | 2 | 2022 | 113 | 0.930 |
Why?
|
| Biopsy, Fine-Needle | 9 | 2022 | 1094 | 0.800 |
Why?
|
| Feedback, Psychological | 1 | 2021 | 97 | 0.760 |
Why?
|
| Contusions | 1 | 2021 | 81 | 0.750 |
Why?
|
| Foam Cells | 1 | 2020 | 71 | 0.730 |
Why?
|
| Breast Neoplasms | 14 | 2024 | 20822 | 0.630 |
Why?
|
| Coloring Agents | 1 | 2020 | 566 | 0.610 |
Why?
|
| Tonsillar Neoplasms | 1 | 2017 | 51 | 0.580 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 193 | 0.560 |
Why?
|
| Triage | 1 | 2023 | 976 | 0.550 |
Why?
|
| Immunoconjugates | 1 | 2022 | 901 | 0.500 |
Why?
|
| Lung Transplantation | 2 | 2020 | 1153 | 0.490 |
Why?
|
| Lymphoma, Follicular | 3 | 2022 | 435 | 0.480 |
Why?
|
| Rare Diseases | 1 | 2017 | 553 | 0.410 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1889 | 0.400 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2024 | 1038 | 0.390 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 1643 | 0.380 |
Why?
|
| Granulomatous Mastitis | 2 | 2019 | 8 | 0.320 |
Why?
|
| Sarcoidosis | 1 | 2014 | 506 | 0.320 |
Why?
|
| Flow Cytometry | 3 | 2022 | 5974 | 0.320 |
Why?
|
| Receptor, erbB-2 | 4 | 2023 | 2416 | 0.310 |
Why?
|
| Patient Care Planning | 1 | 2013 | 921 | 0.300 |
Why?
|
| Macrophages | 1 | 2022 | 5655 | 0.300 |
Why?
|
| Biopsy | 4 | 2023 | 6756 | 0.270 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 1832 | 0.260 |
Why?
|
| Lung | 4 | 2022 | 9856 | 0.250 |
Why?
|
| Attitude to Health | 1 | 2013 | 2052 | 0.240 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 137 | 0.210 |
Why?
|
| Immunohistochemistry | 6 | 2023 | 11366 | 0.200 |
Why?
|
| Neoplasms | 3 | 2022 | 21683 | 0.200 |
Why?
|
| Receptors, Estrogen | 4 | 2019 | 2187 | 0.190 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 135 | 0.190 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2020 | 120 | 0.180 |
Why?
|
| Cytological Techniques | 1 | 2021 | 219 | 0.180 |
Why?
|
| Carcinoid Tumor | 1 | 2021 | 235 | 0.170 |
Why?
|
| Tracheal Stenosis | 1 | 2022 | 226 | 0.170 |
Why?
|
| Humans | 44 | 2024 | 744343 | 0.160 |
Why?
|
| Lymph Nodes | 2 | 2021 | 3474 | 0.160 |
Why?
|
| Gene Amplification | 1 | 2022 | 1063 | 0.150 |
Why?
|
| Female | 26 | 2024 | 380194 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 210 | 0.150 |
Why?
|
| Fungi | 1 | 2020 | 327 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 322 | 0.150 |
Why?
|
| Ascaris suum | 1 | 2016 | 11 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2017 | 155 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
| Observer Variation | 2 | 2020 | 2593 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 538 | 0.140 |
Why?
|
| Trachea | 1 | 2022 | 1076 | 0.130 |
Why?
|
| Optic Nerve Glioma | 1 | 2015 | 32 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.130 |
Why?
|
| Mycophenolic Acid | 1 | 2017 | 343 | 0.130 |
Why?
|
| Pathology, Clinical | 1 | 2019 | 368 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 640 | 0.130 |
Why?
|
| Cytodiagnosis | 1 | 2019 | 435 | 0.130 |
Why?
|
| Airway Obstruction | 1 | 2020 | 664 | 0.130 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 209 | 0.130 |
Why?
|
| Middle Aged | 12 | 2022 | 213383 | 0.120 |
Why?
|
| Tonsillectomy | 1 | 2017 | 255 | 0.120 |
Why?
|
| Erythema Nodosum | 1 | 2014 | 30 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1142 | 0.120 |
Why?
|
| Young Adult | 6 | 2021 | 56430 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 1364 | 0.110 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 382 | 0.110 |
Why?
|
| Sweating | 1 | 2014 | 123 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2023 | 2649 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2016 | 484 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 2014 | 324 | 0.100 |
Why?
|
| Prognosis | 5 | 2024 | 29063 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 1097 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2541 | 0.100 |
Why?
|
| Mastectomy, Segmental | 1 | 2016 | 956 | 0.100 |
Why?
|
| Male | 12 | 2022 | 350118 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3305 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2214 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3586 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 537 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 1 | 2015 | 569 | 0.090 |
Why?
|
| Aged | 9 | 2022 | 163280 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 547 | 0.090 |
Why?
|
| Adult | 10 | 2022 | 214055 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2015 | 1355 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2022 | 77449 | 0.090 |
Why?
|
| Bronchi | 1 | 2014 | 840 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2020 | 1479 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1634 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.080 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 949 | 0.080 |
Why?
|
| Bacteria | 1 | 2020 | 2114 | 0.080 |
Why?
|
| Leiomyosarcoma | 1 | 2013 | 477 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2014 | 862 | 0.080 |
Why?
|
| Astrocytes | 1 | 2015 | 1270 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2013 | 730 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2020 | 41006 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1063 | 0.070 |
Why?
|
| Microglia | 1 | 2015 | 1266 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3920 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 934 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1924 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13102 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 3798 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14722 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1376 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2013 | 1101 | 0.070 |
Why?
|
| Psoriasis | 1 | 2014 | 898 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1641 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4371 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8428 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 9239 | 0.060 |
Why?
|
| Lymphoma | 1 | 2014 | 1877 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5172 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 12959 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 1513 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 85781 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4042 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2266 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5256 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2023 | 162 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2020 | 2716 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Child | 3 | 2020 | 77709 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3557 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11524 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3462 | 0.050 |
Why?
|
| Axilla | 1 | 2023 | 595 | 0.050 |
Why?
|
| Infant | 2 | 2020 | 35136 | 0.050 |
Why?
|
| United States | 3 | 2023 | 69872 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3752 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 6314 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39050 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2023 | 709 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 987 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 847 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 1261 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 19905 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2022 | 1880 | 0.040 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
| RNA, Helminth | 1 | 2016 | 59 | 0.030 |
Why?
|
| Purines | 1 | 2019 | 594 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 542 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2023 | 2924 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2023 | 1584 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 11031 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 4262 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2022 | 1640 | 0.030 |
Why?
|
| Breast | 1 | 2022 | 1969 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3689 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 981 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 691 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3616 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 1202 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.030 |
Why?
|
| Animals | 6 | 2023 | 168757 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2016 | 749 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 486 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15076 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 520 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11124 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2265 | 0.020 |
Why?
|
| Mice | 4 | 2020 | 81183 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2429 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 1701 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 1524 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 1770 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 738 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5391 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
| Phenotype | 1 | 2024 | 16365 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5892 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2759 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2013 | 2967 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5319 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10481 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8324 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8663 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9727 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2013 | 3743 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2011 | 2921 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2149 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
| Contrast Media | 1 | 2011 | 5300 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 21827 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 25625 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63114 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 8863 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 29786 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20129 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(135)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_